A new Amethyst center opened in July 2021, at Timisoara (in the south-west of Romania) providing ambulatory treatment for all cancer types patients. This center is very similar to the Cluj center, with Radiotherapy Department equipped with BigBore Phillips CT, 2 mirrored ELEKTA LINACS providing VMAT/IMRT 6/10 MV with Agility fast MLC and a Medical Oncology Department functioning as Day Unit Hospital. Nutrition and psychological support will be provided in the center.
In Austria around 40,000 people develop cancer every year. About 60 percent of the sick need radiation therapy. There are currently 15 linear accelerators (“Linac” for “linear accelerator”) in operation in Vienna. This means that up to 6,000 patients can be treated per year. It was planned to open another center for radiation oncology and radiation therapy in Vienna in May 2020. Due to the effects of the corona pandemic, the opening had to be postponed to October 1, 2020. The facility is being built and operated by the international company “Amethyst Radiotherapy” on the grounds of the Wiener Privatklinik in 1090 Vienna, Pelikangasse 15. “With our additional linear accelerator, 600 more patients can be treated per year. This is particularly important because time is an essential factor in the treatment process for cancer patients,” explains Dr. Paul Stuchetz, Managing Director Amethyst Radiotherapy Austria. The Amethyst Center for Radiation Oncology and Radiation Therapy is designed in such a way that it can be expanded to include an additional linear accelerator; For example, 17 linear accelerators for radiation therapy will be available in Vienna in the future and the treatment capacity will be significantly increased by up to 1,200 therapies per year – this corresponds to 20 percent. Former Minister of Health Dr. Andrea Kdolsky is very pleased with the opening of the new location: “With every new linear accelerator, the waiting time for a radiation therapy place is shortened. Due to the high capacity with now 16 Linacs in full operation in Vienna, waiting times are significantly reduced. Each additional Linac saves lives.”
Amethyst Radiotherapy is planning further centers for radiation oncology and radiation therapy in Austria and will thus lead to a further increase in treatment capacity. Amethyst Radiation Therapy is Europe’s fastest growing private cancer treatment facility. Amethyst combines the expertise of Europe’s leading cancer experts and the latest and most advanced techniques and equipment to provide patients with the best possible treatment. The focus here is on radiation oncology. Amethyst Radiation Oncology and Radiation Therapy Centers offer the most precise and advanced cancer treatments available. In 2019 alone, Amethyst medical teams comprising more than 100 doctors in ten centers treated over 15,000 cancer patients. The Amethyst Group is a private healthcare facility whose owners have been operating in the European healthcare and pharmaceutical market for 20 years. Amethyst was founded in 2010 and focuses on making the latest radiation therapy technologies available at all locations. Amethyst’s goal is to ensure that cancer patients receive reliable, modern, and operational medical services. Amethyst, a high-performance partner in the healthcare sector, is currently represented with ten centers in five European countries. Amethyst will continue its rapid growth and will operate up to 20 centers with 40 linear accelerators in the coming months.
More information: http://amethyst-radiotherapy.at
Amethyst Radiotherapy expands its footprint into the UK through the acquisition of the 100% share capital of Medical Equipment Solutions Limited (MESL) – a specialised provider of intracranial radiation treatments (using the GammaKnife platform) at Queen Square Radiosurgery Centre in London and the Thornbury Radiosurgery Centre in Sheffield.
Amethyst Radiotherapy now operates twelve radiotherapy centres across six countries with a further twenty either in planning and/or development.
Group CEO, Ludovic Robert, says: “Amethyst Radiotherapy aims to build on the established reputation of Queen Square Radiosurgery Centre, London, and the Thornbury Radiosurgery Centre in Sheffield to provide the best possible, evidence based treatment for patients with previously hard to treat brain lesions.”
Adding: “Amethyst is rigorously focused on delivering the highest quality of service for patients, working in close partnership with leading NHS Centres of Excellence, Neurosurgeons and Oncologists as well as private payors and providers across the wider health economy.” Amethyst expects to further develop its service footprint across the UK. Amethyst Radiotherapy has appointed Stefan Doroszkowski to lead the UK business roll-out. Stefan has worked +25 years across the industry for a wide range of public and private payors and providers.
About Gamma Knife:* Gamma Knife is a non-invasive stereotactic radiosurgery platform that involves no scalpel or incision – it is not a knife at all. Instead, GammaKnife uses up to 201 precisely focused beams of radiation to control malignant and non-malignant tumors, as well as vascular and functional disorders in the brain, without harming surrounding healthy tissue.
Patients are typically in and out of the hospital in a day, and back to their normal routines soon after treatment. GammaKnife radiosurgery may be used in place of – or in addition to – traditional surgery or whole brain radiation, depending on a patient’s diagnosis.
* Gamma Knife is a registered trade-mark of Elekta (https://gammaknife.com/what-is-gamma-knife/). All rights reserved
On February 7th, we inaugurated radiotherapy treatments in stereotactic conditions in Creil (France). Amethyst Radiotherapy is the very first one to propose these state-of-the-art treatments in the department of Oise, hence enabling patients of the region to have their treatment delivered close to their home.
Radiotherapy in stereotactic conditions is a very high precision irradiation technique, which allows to treat with great efficiency small lung cancers and metastases (brain, lung, bone), in a limited number of sessions, often 3 to 5 and, in less than 15 days, with few side effects.
This achievement is the result of major financial investment – in a new linear accelerator and a last-generation repositioning system – combined with a strong commitment of the medical team to always provide the best possible treatments and experience for the patient.
On 8th of November 2019, the center Amethyst of La Garenne-Colombes in France inaugurated its new linear accelerator and opened its premises to medical partners.
Our radiation oncologists gave a tour of the clinic installations to their peers while explaining the latest radiotherapy techniques, including radiation therapy in stereotactic conditions.
Professor Cosset focused on prostate cancer, Dr. Haie-Meder presented brachytherapy treatments and Dr. Chaurin provided an update in Ear, Nose and Throat treatments.
May 2017 marks the first day of the new Amethyst centre in Rome. The grow of the Amethyst network has now reached the Italian Peninsula.
Located in the picturesque Isola Tiberina, an island located inside the Tiber river, the centre stems from a partnership between Amethyst and Fatebenefratelli order, which has run the San Giovanni Calibita Hospital since 1585. The centre is located inside the hospital building. It develops around the ruins of the temple of the ancient roman god of medicine, Aesculapius.
The island has served since the III century BCE as the healthcare centre of Rome. The new investments planned by Amethyst on the site aim at creating a quality-focused, high-technology radiotherapy centre by revamping and completely renovate the existing department.
The centre is equipped with two last generation Varian Linacs complete of all accessories. A shuttle service is also available for all people who have difficulties reaching the Island.
